To test the therapeutic potential of adenine base editing in facioscapulohumeral dystrophy, we targeted the DUX4 polyadenylation signal and achieved efficient DUX4 mRNA downregulation in FSHD muscle cell cultures. This evidence concerns the gene DUX4 and Facioscapulohumeral dystrophy.